Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 10 04:00PM ET
0.9831
Dollar change
-0.0269
Percentage change
-2.66
%
Index- P/E- EPS (ttm)- Insider Own36.91% Shs Outstand102.27M Perf Week8.03%
Market Cap108.79M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float69.82M Perf Month5.71%
Income- PEG- EPS next Q- Inst Own1.75% Short Float0.39% Perf Quarter11.72%
Sales- P/S- EPS this Y- Inst Trans106.08% Short Ratio1.05 Perf Half Y-0.70%
Book/sh- P/B- EPS next Y- ROA- Short Interest0.27M Perf Year66.60%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range0.41 - 1.74 Perf YTD75.55%
Dividend Est.- P/FCF- EPS past 5Y-12.98% ROI- 52W High-43.50% Beta0.63
Dividend TTM- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low139.78% ATR (14)0.08
Dividend Ex-Date- Current Ratio- EPS Y/Y TTM- Oper. Margin- RSI (14)51.88 Volatility8.17% 8.81%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price3.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q7.04% Payout- Rel Volume0.72 Prev Close1.01
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume262.44K Price0.98
SMA202.05% SMA503.09% SMA20016.08% Trades Volume187,719 Change-2.66%
Date Action Analyst Rating Change Price Target Change
Dec-22-20Initiated B. Riley Securities Buy $8
Dec-17-18Initiated Laidlaw Buy
Dec-05-24 07:07AM
Dec-04-24 07:00AM
Nov-20-24 07:28AM
Nov-19-24 07:00AM
Nov-01-24 01:00PM
10:29PM Loading…
Oct-30-24 10:29PM
08:30AM
Oct-26-24 05:49PM
Oct-19-24 05:27PM
Sep-19-24 07:00AM
Aug-19-24 07:00AM
Aug-14-24 07:00AM
Aug-10-24 02:00PM
Jul-24-24 07:00AM
Jun-28-24 11:01AM
07:53AM Loading…
07:53AM
Jun-26-24 07:00AM
Jun-11-24 08:45AM
08:00AM
Jun-06-24 09:00AM
Jun-04-24 09:00AM
May-30-24 07:00AM
May-13-24 07:00AM
Apr-25-24 10:00AM
Apr-23-24 09:32AM
07:00AM
Apr-22-24 07:00AM
Apr-19-24 07:00AM
Apr-18-24 07:00AM
Apr-11-24 07:00AM
07:00AM Loading…
Mar-05-24 07:00AM
Jan-08-24 07:00AM
Jan-05-24 09:30AM
07:00AM
Dec-19-23 07:00AM
Dec-04-23 07:09AM
Nov-30-23 07:00AM
Nov-01-23 07:00AM
Oct-20-23 05:20AM
Oct-18-23 07:00AM
Oct-17-23 03:27AM
Oct-16-23 07:00AM
Oct-13-23 07:00AM
Oct-11-23 07:00AM
Sep-26-23 07:00AM
Sep-12-23 08:19AM
Sep-08-23 07:00AM
Sep-06-23 07:00AM
Aug-28-23 07:12AM
Aug-23-23 10:30AM
07:00AM
Aug-17-23 07:00AM
Aug-15-23 09:28AM
07:00AM
Aug-01-23 08:00AM
Jul-21-23 04:15PM
Jun-20-23 06:07AM
Jun-18-23 09:02AM
Jun-13-23 07:00AM
Jun-05-23 10:00AM
May-25-23 07:00AM
May-23-23 07:00AM
May-17-23 07:00AM
May-05-23 10:49AM
May-02-23 05:52AM
Apr-27-23 07:00AM
Apr-26-23 02:47PM
Apr-24-23 07:00AM
Apr-21-23 10:47AM
Apr-20-23 07:00AM
Apr-19-23 10:30AM
Apr-18-23 07:00AM
Apr-17-23 09:00AM
05:53AM
Apr-13-23 08:30AM
07:00AM
Apr-10-23 07:00AM
Apr-04-23 10:43AM
07:00AM
Mar-31-23 07:00AM
Mar-29-23 06:13AM
Mar-28-23 07:00AM
Mar-22-23 07:00AM
Mar-21-23 07:00AM
Mar-20-23 08:00AM
Mar-17-23 08:10AM
07:00AM
06:03AM
Mar-09-23 07:05AM
Mar-08-23 07:00AM
Feb-09-23 05:24AM
Jan-08-23 08:53AM
Jan-04-23 07:00AM
Jan-03-23 11:11AM
07:00AM
Dec-29-22 05:00PM
Dec-27-22 05:00PM
Dec-16-22 07:00AM
Dec-15-22 07:00AM
Dec-14-22 06:00AM
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. It specializes in developing transformative therapies for neurodegenerative and lung diseases. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.